"From cutting-edge cancer treatments to wellness classes, education and support services, Springfield Regional Cancer Center has everything you need. All in a single facility-all in an environment that's as peaceful and healing as it is advanced"

During the past decade, Springfield Regional Cancer Center conducted 130 clinical trials. In the 10-year time frame, 130 clinical trials started and 47 clinical trials were completed, i.e. on average, 36.2% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 45 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Springfield Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 71 trials, followed by "SWOG Cancer Research Network" with 37 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "NRG Oncology" with 17 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Springfield Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 91 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Springfield Regional Cancer Center" are "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Springfield Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Springfield Regional Cancer Center" are "Drug" (136 trials), "Other" (88 trials), "Biological" (66 trials), "Procedure" (46 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (35 trials), "Computed Tomography" (25 trials), "Biospecimen Collection" (24 trials) and "Nivolumab" (21 trials). Other intervention names were less common.

The vast majority of trials in "Springfield Regional Cancer Center" are 136 trials for "All" genders, 20 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Springfield Regional Cancer Center". undefined are not yet recruiting, 56 are recruiting, 67 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Springfield Regional Cancer Center, 3 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Springfield Regional Cancer Center, 3 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".